Search results
Hims & Hers Selling GLP-1 Weight Loss Drugs Like Wegovy for 85% Less: What to Know
Healthline via AOL· 4 days agoTelehealth company Hims & Hers announced they will begin selling off-brand GLP-1 drugs similar to...
New Analysis Confirms Wegovy Can Sustain Weight Loss for 4 Years and Support Heart Health
MSN News· 4 days agoFact checked by Nick BlackmerFact checked by Nick Blackmer Key Takeaways A new analysis shows that Wegovy is effective for long-term weight loss, with users maintaining weight ...
Bye bye Taylor Swift's jet, weight loss drug research, and summer travel spots: Lifestyle news...
Quartz· 1 day agoNew research this month is the latest to link the use of Ozempic, Wegovy, and other GLP-1 drugs to a...
Use of Wegovy and other weight-loss drugs soars among kids
Southwest Iowa's daily newspaper· 4 days agoNew research shows the number of 12- to 25-year-olds who used diabetes and obesity drugs such as ...
Use of Wegovy and other weight-loss drugs soars among kids and young adults
The News-Times· 4 days agoAt 17, Israel McKenzie was so burdened by obesity that he stopped going to high school in person and...
Hims & Hers Now Selling Off-Brand Ozempic, Wegovy for $199
Healthline· 4 days agoHims & Hers is now selling compounded semaglutide for weight loss. Compounded medications undergo...
Drugs like Ozempic could protect kidney health in people with heart disease, obesity
MedicalNewsToday via AOL· 1 day agoData from a new clinical trial suggest that people with obesity and cardiovascular disease who use...
Wegovy, Saxenda study reveals surprising trend for weight loss drugs
USA Today· 5 days agoMore than half of people prescribed weight-loss drugs Saxenda and Wegovy over the past decade ended...
Nestlé announces plans to launch frozen foods targeting Ozempic and Wegovy users
The Independent via Yahoo Finance· 5 days agoNestlé has announced plans to launch frozen foods that target weight-loss drug users. In the last...
Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
Motley Fool via Yahoo Finance· 5 hours agoThat means the drug could one day compete for the market shares of Eli Lilly's marketed medicines...